Clinical trial

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

NCT02266563

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Amyvid PET Scan Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention T807 PET scan Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-01-01

PhaseN/A

Conditions

Traumatic Brain Injuryverified · MONDO: traumatic brain injury

Chronic Traumatic Encephalopathyverified · MONDO: dementia pugilistica

Mild Cognitive Impairmentunresolved

Interventions

Amyvid PET ScanDRUG

T807 PET scanDRUG

Sponsors & collaborators

Samuel Gandylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02266563 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.